Skip to main content
EMR
NYSE Manufacturing

Emerson Reports Mixed Q2 Results, Updates 2026 Outlook, and Appoints New Director

Analysis by Arik Shkolnikov
Sentiment info
Neutral
Importance info
7
Price
$136
Mkt Cap
$77.811B
52W Low
$106.53
52W High
$165.15
Market data snapshot near publication time

summarizeSummary

Emerson Electric reported mixed Q2 2026 results with increased EPS but decreased cash flow, provided updated full-year and Q3 guidance, and announced the appointment of Jennifer G. Newstead, SVP & General Counsel at Apple, to its Board of Directors.


check_boxKey Events

  • Q2 2026 Financial Performance

    Emerson reported Q2 2026 GAAP EPS of $1.10 (up 28%) and Adjusted EPS of $1.54 (up 4%). Net sales increased 3% to $4.56 billion. Operating cash flow and free cash flow both decreased by 6%.

  • Updated Fiscal Year 2026 Outlook

    The company updated its full-year 2026 guidance, projecting approximately 4.5% net sales growth and adjusted EPS between $6.45 and $6.55. Q3 guidance includes ~5.5% net sales growth and adjusted EPS of $1.65-$1.70.

  • New Director Appointed to Board

    Jennifer G. Newstead, Senior Vice President and General Counsel of Apple (formerly Chief Legal Officer at Meta), was elected as a Director, effective August 3, 2026. She will serve on the Compensation and Corporate Governance & Nominating Committees.


auto_awesomeAnalysis

Emerson Electric reported a mixed second quarter, with GAAP EPS increasing significantly and adjusted EPS showing modest growth, driven by resilient demand and better-than-expected margins. However, operating and free cash flow saw a decline. The company also provided updated full-year and third-quarter guidance, which will be crucial for investor expectations. Additionally, the appointment of Jennifer G. Newstead, a high-profile legal executive from Apple and Meta, to the Board of Directors is a positive development, enhancing the board's expertise in corporate governance and technology policy.

At the time of this filing, EMR was trading at $136.00 on NYSE in the Manufacturing sector, with a market capitalization of approximately $77.8B. The 52-week trading range was $106.53 to $165.15. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed EMR - Latest Insights

EMR
May 05, 2026, 4:13 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
EMR
May 05, 2026, 4:06 PM EDT
Filing Type: 8-K
Importance Score:
7
EMR
May 04, 2026, 4:38 AM EDT
Source: Zawya
Importance Score:
7
EMR
Apr 21, 2026, 1:04 AM EDT
Source: Zawya
Importance Score:
7
EMR
Feb 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7